| Literature DB >> 28059134 |
Nur Ahmad Kamil Zati Iwani1,2, Muhammad Yazid Jalaludin1, Ruziana Mona Wan Mohd Zin1,2, Md Zain Fuziah3, Janet Yeow Hua Hong3, Yahya Abqariyah4, Abdul Halim Mokhtar5, Wan Mohamud Wan Nazaimoon2.
Abstract
The purpose of this study was to investigate the usefulness of triglyceride to hdl-c ratio (TG:HDL-C) as an insulin resistance (IR) marker for overweight and obese children. A total of 271 blood samples of obese and overweight children aged 9-16 years were analysed for fasting glucose, lipids and insulin. Children were divided into IR and non-insulin resistance, using homeostasis model assessment (HOMA). The children were then stratified by tertiles of TG: HDL-C ratio. The strength between TG:HDL-C ratio and other parameters of IR were quantified using Pearson correlation coefficient (r). Odds ratio was estimated using multiple logistic regression adjusted for age, gender, pubertal stages and IR potential risk factors. Children with IR had significantly higher TG:HDL-C ratio (2.48) (p = 0.01). TG:HDL-C ratio was significantly correlated with HOMA-IR (r = 0.104, p < 0.005) and waist circumference (r = 0.134, p < 0.001). Increasing tertiles of TG:HDL-C ratio showed significant increase in mean insulin level (p = 0.03), HOMA-IR (p = 0.04) and significantly higher number of children with acanthosis nigricans and metabolic syndrome. The odds of having IR was about 2.5 times higher (OR = 2.47; 95% CI 1.23, 4.95; p = 0.01) for those in the highest tertiles of TG:HDL-C ratio. Hence, TG:HDL-C may be a useful tool to identify high risk individuals.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28059134 PMCID: PMC5216403 DOI: 10.1038/srep40055
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow chart for blood data used for TG:HDL-C ratio sub study.
Clinical characteristics of 271 children.
| Boys | Girls | P value | All | |
|---|---|---|---|---|
| N (%) | 133 (49.1) | 138 (50.9) | NS | 271 |
| Age, median (p25, p75) | 13 (11, 14) | 14 (13, 14) | 0.004 | 14 (11, 14) |
| Pre-pubertal (n (%)) | 46 (37.4) | 29 (22.1) | 0.008 | 75 (29.5) |
| Pubertal (Tanner Stage ≥ 2) (n (%)) | 77 (62.6) | 102 (77.9) | 179 (70.5) | |
| Overweight (n (%)) | 21 (15.8) | 40 (29) | 0.009 | 61 (22.5) |
| Obese (n (%)) | 112 (84.2) | 98 (71) | 210 (77.5) | |
| Within Normal range | 121 (91) | 132 (100) | 0.04 | 253 (98.4) |
| With Hypertension | 4 (9) | 0 (0) | 4 (1.6) | |
| Median Systolic Blood Pressure (mmHg) (p25, p75) | 110 (100, 120) | 110 (110, 116) | NS | 110 (100, 120) |
| Median Diastolic Blood Pressure (mmHg) (p25, p75) | 70 (68, 80) | 70 (60, 76) | 0.002 | 70 (62, 80) |
| Present | 52 (41.9) | 83 (63.8) | <0.001 | 135 (53.1) |
| Absent | 72 (58.1) | 47 (36.2) | 119 (46.9) | |
| No Metabolic Syndrome | 116 (87.2) | 127 (92) | NS | 243 (89.7) |
| With Metabolic Syndrome | 17 (12.8) | 11 (8) | 28 (10.3) | |
Missing data: 17 in pubertal status, 17 in acanthosis nigricans, 17 in insulin resistance.14 in blood pressure status NS: Not Significant.
Anthropometric and Biochemical Measurements of 271 children.
| Boys | Girls | P value | All | |
|---|---|---|---|---|
| Median BMI z-score (p25, p75) | 2.9 (2.4, 3.3) | 2.4 (1.9, 2.8) | <0.001 | 2.6 (2.1, 3) |
| Median Waist Circumference (cm) (p25, p75) | 89 (83.2, 99.9) | 85 (79.5, 90) | 0.011 | 87 (81, 94) |
| Mean Body Fat (%) | 38.7 ± 6.7 | 42.5 ± 4.7 | <0.001 | 40.7 ± 6.1 |
| Median Fasting Plasma Glucose (mmol/l) (p25, p75) | 5.3 (5, 5.5) | 5.2 (4.3, 8.5) | NS | 5.3 (5, 5.6) |
| Median HbA1c (%) (p25, p75) (mmol/mol) | 5.3 (5, 5.5) 34 (31, 37) | 5.2 (5, 5.5) 33 (31, 37) | NS | 5.2 (5, 5.4) 33 (31, 36) |
| Mean Total Cholesterol (mmol/l) | 4.6 ± 0.8 | 4.6 ± 0.8 | NS | 4.6 ± 0.8 |
| Median Triglycerides (mmol/l) (p25, p75) | 1.1 (0.8, 1.5) | 0.9 (0.8, 1.3) | NS | 1.0 (0.8, 1.4) |
| Median HDL-C (mmol/l) (p25, p75) | 1.1 (1, 1.2) | 1.1 (1, 1.3) | NS | 1.1 (1, 1.3) |
| Mean LDL-C (mmol/l) | 3.3 ± 0.9 | 3.2 ± 0.9 | NS | 3.2 ± 0.8 |
| Median TG:HDL-C ratio (p25, p75) | 2.1 (1.6, 2.99) | 1.9 (1.5, 2.7) | NS | 2.0 (1.5, 2.78) |
NS: Not significant.
Clinical characteristics of children with insulin resistance (IR) and with no insulin resistance (non-IR).
| Clinical parameters | IR (n = 126) | Non-IR (n = 131) | p-Value |
|---|---|---|---|
| Mean Total Cholesterol (mmol/l) | 4.6 ± 0.8 | 4.5 ± 0.8 | 0.09 |
| Median TG (mmol/l) (p25, p75) | 1.1 (0.9, 1.4) | 0.9 (0.7, 1.2) | 0.001 |
| Median HDL-C (mmol/l) (p25, p75) | 1.1 (1.0, 1.2) | 1.1 (1.0, 1.3) | NS |
| Median LDL-C (mmol/l) (p25, p75) | 3.2 (2.7, 3.8) | 3.1 (2.5, 3.6) | 0.04 |
| Median TG:HDL-C (p25, p75) | 2.48 (1.6, 3.1) | 1.73 (1.4, 2.6) | 0.01 |
| Mean Systolic Blood Pressure (mmHg) | 109.6 ± 10 | 109.5 ± 10 | NS |
| Mean Diastolic Blood Pressure (mmHg) | 69.7 ± 10 | 70.9 ± 8 | NS |
| Median BMI z-score (p25, p75) | 2.7 (2.3, 3.2) | 2.5 (1.8, 2.9) | <0.001 |
| Median Waist Circumference (cm) (p25, p75) | 89 (83.3, 96.5) | 85 (79, 90) | <0.001 |
| Median Body Fat (%) (p25, p75) | 42 (38.9, 46.3) | 39.9 (35.2, 43.3) | <0.001 |
NS: not significant.
aIndependent sample t-test.
bMann-Whitney U test.
Correlation between TG:HDL ratio and other parameters of insulin resistance (IR).
| LDL | HDL | HOMA | BMI z-score | WC | TG:HDL-C | |
|---|---|---|---|---|---|---|
| TC | 0.931 | 0.523 | 0.091 | 0.014 | 0.000 | −0.01 |
| LDL | 0.238 | 0.081 | 0.081 | 0.039 | 0.05 | |
| HDL | 0.039 | −0.12 | −0.161 | −0.468 | ||
| HOMA | 0.202 | 0.258 | 0.134 | |||
| BMI z-score | 0.547 | 0.104 | ||||
| WC | 0.173 |
TG: triglyceride, TC: total cholesterol, LDL: low-density lipoprotein, HDL: high-density lipoprotein, HOMA-IR: homeostasis model assessment of insulin resistance, BMI z-score: age and sex- corrected body mass index, TG:HDL-C ratio of TG to HDL. Correlation was estimated using Pearson correlation coefficient. *P < 0.05, **P < 0.000.
Anthropometric, clinical and metabolic parameters across TG:HDL-C ratio tertiles.
| First tertile (25th centile) | Second tertile (50th centile) | Third tertile (75th centile) | P value | |
|---|---|---|---|---|
| n | 90 | 91 | 90 | |
| Age (y), mean (sd) | 13.1 ± 2.3 | 13.1 ± 2.0 | 12.9 ± 1.9 | NS |
| Male, n (%) | 41 | 46 | 46 | NS |
| Female, n (%) | 49 | 45 | 45 | NS |
| Pre-Pubertal, n (%) | 21 | 28 | 26 | NS |
| Pubertal, n (%) | 65 | 54 | 60 | NS |
| Present | 39 (28.9) | 38 (28.1) | 58 (43) | 0.005 |
| Absent | 46 (38.7) | 45 (37.8) | 28 (23.5) | |
| No Metabolic Syndrome | 85 (34.9) | 86 (35.4) | 72 (29.7) | 0.001 |
| With Metabolic Syndrome | 5 (17.9) | 5 (17.9) | 18 (64.2) | |
| Within Normal range systolic and/or diastolic blood pressure | 87 (34.4) | 82 (32.8) | 84 (32.8) | NS |
| With Hypertension | 1 (16.7) | 1 (44.4) | 2 (38.9) | |
| BMI z-score, mean (sd) | 2.4 ± 0.8 | 2.6 ± 0.8 | 2.8 ± 0.8 | 0.03 |
| Waist Circumference (cm), mean (sd) | 85.7 ± 10.3 | 88.4 ± 9.4 | 90.5 ± 9.7 | <0.01 |
| Body Fat Mass (kg), mean (sd) | 25.5 ± 8.2 | 27.4 ± 8.4 | 28.7 ± 8.6 | NS |
| Body Fat (%), mean (sd) | 39.9 ± 5.8 | 40.9 ± 6.1 | 41.2 ± 6.3 | NS |
| Systolic Blood Pressure (mmHg), mean (sd) | 108 ± 10.4 | 110.3 ± 10.2 | 110.7 ± 10.9 | NS |
| Diastolic Blood Pressure (mmHg), mean (sd) | 69.8 ± 9.2 | 69.8 ± 10.8 | 71.7 ± 9.4 | NS |
| Fasting Plasma Glucose (mmol/l), mean (sd) | 5.3 ± 0.5 | 5.4 ± 0.5 | 5.7 ± 2.8 | NS |
| Total Cholesterol (mmol/l), mean (sd) | 4.5 ± 0.8 | 4.6 ± 0.7 | 4.6 ± 0.9 | NS |
| TG (mmol/l), mean (sd) | 0.7 ± 0.1 | 1.0 ± 0.2 | 1.6 ± 0.4 | <0.001 |
| HDL-C (mmol/l), mean (sd) | 1.3 ± 0.2 | 1.1 ± 0.2 | 1.1 ± 0.2 | <0.001 |
| Mean LDL-C (mmol/l), mean (sd) | 3.1 ± 0.9 | 3.3 ± 0.7 | 3.3 ± 1.0 | NS |
| Mean TG:HDL-C ratio, mean (sd) | 1.28 ± 0.27 | 2.1 ± 0.27 | 3.5 ± 1.0 | <0.001 |
| Mean Insulin (mU/mL), mean (sd) | 15.1 ± 8 | 21.4 ± 29 | 22.0 ± 14.5 | 0.03 |
| HOMA-IR, mean (sd) | 3.6 ± 2.3 | 5.2 ± 7.5 | 6.1 ± 8.4 | 0.04 |
NS: Not significant.
Associated factors of IR by simple and multiple logistic regression among obese and overweight students.
| Variables | Univariate analysis | Multiple variable analysis | ||||
|---|---|---|---|---|---|---|
| b | Crude OR (95% CI) | p-value | b | Adjusted OR (95% CI) | p-value | |
| Tertile 1 (25th percentile) | — | — | 0.02 | — | — | |
| Tertile 2 (50th percentile) | 0.62 | 1.87 (1.00, 3.47) | 0.048 | 0.53 | 1.69 (0.85, 3.37) | 0.14 |
| Tertile 3 (75th percentile) | 1.1 | 2.99 (1.6, 5.58) | 0.01 | 0.90 | 2.47 (1.23, 4.95) | 0.01 |
| Age | −0.25 | 0.78 (0.45, 1.32) | 0.35 | −0. 70 | 0.51 (0.15, 1.7) | 0.28 |
| Gender | 0.624 | −0.44 | 1.7 (0.93, 3.1) | 0.09 | ||
| Male | 0.123 | 1.13 (0.69, 1.8) | — | — | ||
| Female | −0.123 | 0.884 (0.54, 1.45) | — | — | ||
| Pubertal stage | 0.228 | −0.13 | 0.88 (0.31, 2.49) | 0.51 | ||
| Pre-pubertal | 0.333 | 1.395 (0.81, 2.4) | — | — | ||
| Pubertal | −0.333 | 0.7 (0.42, 1.23) | — | — | ||
| Waist circumference | 0.07 | 1.07 (1.04, 1.1) | <0.001 | 0.081 | 1.08 (1.03, 1.13) | 0.001 |
| BMI-z score | 0.66 | 1.93 (1.36, 2.75) | <0.001 | 0.007 | 1.00 (0.56, 1.8) | 0.983 |
b = regression coefficients, OR = odds ratio, CI = confidence interval. Multivariate regression analysis was applied. Hosmer Lemeshow Test (chi-square = 5.56, p-value = 0.696) and classification table (overall correctly classified percentage = 67.5%).